| Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction (NCT01547598) | Allergan | 2011-12-01 |
| Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect (NCT01491867) | Semmelweis University | 2011-12-01 |
| Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients (NCT01467388) | University of Zurich | 2011-11-01 |
| Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines (NCT01467440) | University of Zurich | 2011-11-01 |
| Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% (NCT01452009) | Alcon Research | 2011-11-01 |
| Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01568008) | Allergan | 2011-10-01 |
| Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) (NCT01464424) | Alcon Research | 2011-10-01 |
| A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% (NCT01426867) | Alcon Research | 2011-09-01 |
| Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT01489670) | Allergan | 2011-09-01 |
| Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada (NCT01415401) | Alcon Research | 2011-09-01 |
| Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost (NCT01430923) | Aurolab | 2011-09-01 |
| Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT01410188) | Kubota Vision Inc. | 2011-09-01 |
| Efficacy of Changing to DUOTRAV® From Prior Therapy (NCT01327599) | Alcon Research | 2011-08-01 |
| A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (NCT02020512) | Allergan | 2011-07-01 |
| Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C (NCT01312454) | Alcon Research | 2011-06-01 |
| Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01298700) | Allergan | 2011-05-31 |
| 24-hour Efficacy of AR-12286 (NCT01330979) | Aerie Pharmaceuticals | 2011-05-01 |
| Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01309204) | Alcon Research | 2011-05-01 |
| Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01310777) | Alcon Research | 2011-05-01 |
| DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% (NCT01342081) | Santen Pharmaceutical Co., Ltd. | 2011-05-01 |
| DE-111 Against Timolol Ophthalmic Solution 0.5% (NCT01342094) | Santen Pharmaceutical Co., Ltd. | 2011-05-01 |
| Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT01291108) | Allergan | 2011-04-01 |
| Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy (NCT01263444) | Alcon Research | 2011-03-01 |
| Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) (NCT01162603) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2011-03-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT01241240) | Allergan | 2011-03-01 |
| Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations (NCT01306461) | Santen Oy | 2011-03-01 |
| Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies (NCT01292460) | Santen Oy | 2011-02-01 |
| Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% (NCT01297517) | Alcon Research | 2011-02-01 |
| AR-12286 in Combination With Latanoprost (NCT01302249) | Aerie Pharmaceuticals | 2011-02-01 |
| Divided Dose of TRAVATAN® (NCT01298687) | Alcon Research | 2011-02-01 |
| Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT01279083) | Santen Inc. | 2011-01-01 |
| 24-hour IOP-lowering Effect of 0.01% Bimatoprost (NCT01271686) | University of California, San Diego | 2011-01-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT01217606) | Allergan | 2011-01-01 |
| Long-Term Non-Interventional Latanoprost Study (NCT01265719) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT01253902) | Allergan | 2010-12-01 |
| A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01628614) | Allergan | 2010-11-01 |
| Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension (NCT00945958) | Sun Pharma Advanced Research Company Limited | 2010-11-01 |
| Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease (NCT01254370) | Santen SAS | 2010-11-01 |
| Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension (NCT01216943) | Allergan | 2010-11-01 |
| Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01177098) | Allergan | 2010-10-01 |
| Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01215786) | Allergan | 2010-10-01 |
| Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension (NCT01191008) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT01229982) | Mati Therapeutics Inc. | 2010-10-01 |
| Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension (NCT01229462) | Allergan | 2010-10-01 |
| SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg (NCT01227291) | Sylentis, S.A. | 2010-10-01 |
| Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure (NCT01033422) | Can-Fite BioPharma | 2010-10-01 |
| Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension (NCT01157364) | Allergan | 2010-09-23 |
| Central Corneal Thickness With SENSIMED Triggerfish (NCT01210963) | Sensimed AG | 2010-09-01 |
| A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension (NCT01168414) | Ministry of Health, Malaysia | 2010-08-01 |
| The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma (NCT01369771) | FinnMedi Oy | 2010-08-01 |
| Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension (NCT00947661) | Sun Pharma Advanced Research Company Limited | 2010-07-01 |
| A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension (NCT02003534) | Allergan | 2010-07-01 |
| Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01110499) | Allergan | 2010-06-01 |
| GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy (NCT01628601) | Allergan | 2010-05-01 |
| A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01123785) | Inotek Pharmaceuticals Corporation | 2010-05-01 |
| Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension (NCT01099774) | Allergan | 2010-05-01 |
| A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension (NCT02061683) | Allergan | 2010-04-19 |
| Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension (NCT01111890) | Alcon Research | 2010-04-01 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops (NCT01087671) | Santen Oy | 2010-04-01 |
| Travoprost Five Day Posology Study (NCT01114893) | Alcon Research | 2010-04-01 |
| Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01628588) | Allergan | 2010-03-01 |
| Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT01068964) | Allergan | 2010-02-01 |
| Efficacy Comparison of Xalatan and Azopt on POAG and OH (NCT01084902) | Peking University First Hospital | 2010-02-01 |
| Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom (NCT01206361) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-02-01 |
| A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) (NCT01632423) | Allergan | 2010-02-01 |
| Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) (NCT01026831) | Merck Sharp & Dohme LLC | 2010-01-06 |
| A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 (NCT00934089) | Pfizer | 2010-01-01 |
| Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00872651) | Alcon Research | 2010-01-01 |
| Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® (NCT01170884) | Allergan | 2009-12-01 |
| A Study of LUMIGAN® RC in the Clinical Setting (NCT01833741) | Allergan | 2009-12-01 |
| A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG (NCT01037036) | Mati Therapeutics Inc. | 2009-12-01 |
| Use of an Ocular Telemetry Sensor in Diamox Treated Patients (NCT01028664) | Sensimed AG | 2009-12-01 |
| Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution (NCT01001195) | Allergan | 2009-11-01 |
| Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination (NCT00961649) | Alcon Research | 2009-10-01 |
| Safety and Efficacy of a Drug Delivery System in Glaucoma (NCT01016691) | Vistakon Pharmaceuticals | 2009-10-01 |
| Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 (NCT00990743) | Sylentis, S.A. | 2009-09-01 |
| Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure (NCT00941525) | Aristotle University Of Thessaloniki | 2009-09-01 |
| Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea (NCT01976624) | Allergan | 2009-08-01 |
| Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00928590) | Alcon Research | 2009-07-01 |
| Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination (NCT00941096) | Larissa University Hospital | 2009-07-01 |
| Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00761709) | Alcon Research | 2009-07-01 |
| Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health (NCT00892762) | Alcon Research | 2009-06-01 |
| Equivalence Study of Dorzolamide 2% Eye Drops Solution (NCT00878917) | Alfred E. Tiefenbacher (GmbH & Co. KG) | 2009-04-01 |
| A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy (NCT01637246) | Allergan | 2009-04-01 |
| A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT00855517) | Mati Therapeutics Inc. | 2009-03-01 |
| Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension (NCT00868894) | Santen Inc. | 2009-03-01 |
| Safety and Efficacy Study of DuoTrav APS Versus DuoTrav (NCT00862472) | Alcon Research | 2009-03-01 |
| DuoTrav® Eye Drops As Replacement Therapy Program (NCT00828906) | Alcon Research | 2009-02-01 |
| Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT00809848) | Allergan | 2009-02-01 |
| Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension (NCT00761995) | Alcon Research | 2009-02-01 |
| Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma (NCT00845299) | Mati Therapeutics Inc. | 2009-01-01 |
| Safety and Efficacy of Combigan® Ophthalmic Solution in Korea (NCT01987752) | Allergan | 2009-01-01 |
| Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension (NCT00846989) | Novartis Pharmaceuticals | 2009-01-01 |
| A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma (NCT00820300) | Mati Therapeutics Inc. | 2009-01-01 |
| A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs (NCT00823043) | Vistakon Pharmaceuticals | 2009-01-01 |
| A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin (NCT00834171) | Allergan | 2009-01-01 |
| Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma (NCT01361841) | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 2009-01-01 |
| A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma (NCT00887029) | Ophthalmic Consultants Centres, Canada | 2009-01-01 |
| Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning (NCT01261871) | United States Naval Medical Center, San Diego | 2008-12-01 |
| The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) (NCT00815373) | Meir Medical Center | 2008-12-01 |